Washington, D.C. – PSI is excited to announce that it has been successfully awarded a new contract by USAID to support the Presidents Malaria Initiative to Advance the Progress of Malaria Service Delivery (APMSD) in 30 malaria-affected countries. The project, worth over $160 million USD over five years, will be delivered by a consortium of core partners, led by PSI and including JHPIEGO, Medical Care Development International (MCDI) and University of California, San Francisco (UCSF).
The project will focus on supporting national malaria control programs in USAID-supported Malaria Endemic countries including 27 in Africa and three in Asia. The interventions aim to improve quality of and access to malaria case management and malaria in pregnancy interventions. They will also improve quality of and access to other malaria drug-based approaches and provide support to pilot/scale-up newer malaria drug-based approaches. Global technical leadership, support for operational research, and advances in program learning are priorities as well. In addition to the core team, private sector partner Akros and University of Oslo and Medicines for Malaria Venture will support.
Globally, the world has made remarkable progress in controlling malaria; halving the burden of disease between 2000 and 2015, but progress is stalling. The WHO’s most recent World Malaria Report highlights the current state of case management of children under five years and delivery of intermittent presumptive treatment for pregnant women as major concerns.
The U.S. President’s Malaria Initiative, led by USAID and implemented with the U.S. Centers for Disease Control and Prevention, is the U.S. Government’s primary vehicle for assisting malaria affected countries to scale up proven malaria control and elimination interventions.
The PMI Strategy for 2015-2020 accounts for much progress over the past decade and offers a strategy for new and emerging challenges. Malaria prevention and control remains a major US foreign assistance objective and PMI’s strategy fully aligns with the US Government’s vision of ending preventable child and maternal deaths and protecting communities from infectious diseases. By working with PMI-supported countries and partners, the US Government aims to further reduce malaria deaths and substantially decrease malaria morbidity, towards the long-term goal of elimination.
This new contract comes as PSI launches its new global strategy for consumer-powered healthcare. APMSD will innovate ways to bring healthcare closer to the consumer in developing countries. PSI is proud to be associated with USAID and its partners to achieve this goal.
PSI is a leading global health organization working in malaria, HIV, modern contraception and reproductive health, non-communicable diseases and sanitation. Partnering with the public sector and harnessing the power of markets, PSI provides lifesaving products, services and communications that empower vulnerable populations to lead healthier lives.
Learn more at staging.psi-2017.flywheelsites.com.